Literature DB >> 16901476

MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine.

Yan-Jun Xu1, Harjot K Saini, Ming Zhang, Vijayan Elimban, Naranjan S Dhalla.   

Abstract

OBJECTIVE: The Ca2+ -paradox is an important phenomenon to study cell injury induced by Ca2+ -overload in myocardium. Although intracellular Ca2+ -overload acts as a trigger and modulator of cell death due to apoptosis under various pathophysiological conditions, the presence of apoptosis in hearts subjected to Ca2+ -paradox has not been demonstrated. Since taurine attenuates the changes in cardiac function due to Ca2+ -paradox, this study investigated the occurrence and mechanisms of apoptosis in Ca2+ -paradoxic hearts treated in the absence and presence of taurine.
METHODS: Ca2+ -paradox was induced by perfusing the isolated rat heart with Ca2+ -free medium for 5 min followed by reperfusion with Ca2+ -containing medium for 30 min. Apoptosis related signal transduction mechanisms were determined in Ca2+ -paradoxic hearts perfused with or without 10 mM taurine.
RESULTS: Marked alterations in cardiac function and the presence of apoptosis were seen in Ca2+ -paradoxic hearts reperfused for 30 min. Unlike the total protein contents in hearts subjected to Ca2+ -paradox, the contents of phosphorylated p38 mitogen-activated protein kinase (MAPK), extracellular signal regulated kinase (ERK)1, ERK2 and c-jun amino-terminal kinase were increased by 125 +/- 8.6%, 296 +/- 14.3%, 213 +/- 8.5% and 133 +/- 4.2%, respectively vs. control. Caspase-3 and phosphorylated Bcl-2 contents were also increased by 193 +/- 10.2% and 134 +/- 5.0% vs. control whereas phosphorylated Bad and the ratio of Bcl-2/Bad were depressed by 32 +/- 10.8% and 0.23 +/- 0.5% vs. control in Ca2+ -paradoxic hearts. The apoptosis as seen in Ca2+ -paradoxic hearts reperfused for 30 min was not evident in hearts at 10 min Ca2+ -repletion but was similar to hearts subjected to 60 min Ca2+ -repletion. These changes in the apoptotic pathway in cardiomyocytes subjected to Ca2+ -paradox were prevented by taurine. Furthermore, taurine attenuated the KCl- or ATP-induced increase in intracellular concentration of Ca2+ in cardiomyocytes.
CONCLUSIONS: This study suggests that cardiac dysfunction due to Ca2+ -paradox may be associated with apoptosis. In addition, the beneficial effects of taurine on cardiac function may be related to the attenuation of changes in MAPK and apoptotic signal transduction mechanisms in Ca2+ -paradoxic hearts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16901476     DOI: 10.1016/j.cardiores.2006.06.028

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  12 in total

1.  Effects of amino acid supplementation on myocardial cell damage and cardiac function in diabetes.

Authors:  Paramjit S Tappia; James Thliveris; Yan-Jan Xu; Nina Aroutiounova; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2011

2.  Taurine protects cardiac contractility in killifish, Fundulus heteroclitus, by enhancing sarcoplasmic reticular Ca2+ cycling.

Authors:  Elenor F Henry; Tyson J MacCormack
Journal:  J Comp Physiol B       Date:  2017-05-23       Impact factor: 2.200

3.  Suppression of phosphorylated MAPK and caspase 3 by carbon dioxide.

Authors:  Yan-Jun Xu; Vijayan Elimban; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2017-05-29       Impact factor: 3.396

Review 4.  Taurine in health and diseases: consistent evidence from experimental and epidemiological studies.

Authors:  Yukio Yamori; Takashi Taguchi; Atsumi Hamada; Kazuhiro Kunimasa; Hideki Mori; Mari Mori
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

5.  Low cardiovascular risks in the middle aged males and females excreting greater 24-hour urinary taurine and magnesium in 41 WHO-CARDIAC study populations in the world.

Authors:  Yukio Yamori; Takashi Taguchi; Hideki Mori; Mari Mori
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

6.  The potential health benefits of taurine in cardiovascular disease.

Authors:  Yan-Jun Xu; Amarjit S Arneja; Paramjit S Tappia; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2008

7.  Comparison of fractal dimension and Shannon entropy in myocytes from rats treated with histidine-tryptophan-glutamate and histidine-tryptophan cetoglutarate.

Authors:  Marcos Aurélio Barboza de Oliveira; Antônio Carlos Brandi; Carlos Alberto dos Santos; Paulo Henrique Husseni Botelho; José Luís Lasso Cortez; Moacir Fernandes de Godoy; Domingo Marcolino Braile
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Apr-Jun

Review 8.  Protein Kinases as Drug Development Targets for Heart Disease Therapy.

Authors:  Naranjan S Dhalla; Alison L Müller
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-05

9.  TNF-alpha-mediated signal transduction pathway is a major determinant of apoptosis in dilated cardiomyopathy.

Authors:  Samarjit Das; Andrea P Babick; Yan-Jun Xu; Nobuakira Takeda; Delfin Rodriguez-Levya; Naranjan S Dhalla
Journal:  J Cell Mol Med       Date:  2009-09-14       Impact factor: 5.310

10.  Comparison of the solution of histidine-tryptophan-alfacetoglutarate with histidine-tryptophan-glutamate as cardioplegic agents in isolated rat hearts: an immunohistochemical study.

Authors:  Marcos Aurélio Barboza de Oliveira; Lívia Carvalho Ferreira; Débora Aparecida Pires de Campos Zuccari; Antônio Carlos Brandi; Carlos Alberto dos Santos; Paulo Henrique Husseni Botelho; Orlando Petrucci; Domingo Marcolino Braile
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.